Drug Trial Radar · NCT05536752
QA102 Phase II Study in Subjects With Dry AMD
Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Sep 22, 2022
Primary completion
Nov 12, 2024
Study completion Nov 12, 2024
Sponsor
- Lead sponsor
- Smilebiotek Zhuhai LimitedIndustry
- Sponsor type
- Industry
- First posted
- Sep 13, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, double-masked, randomized, placebo-controlled, dose-response study. The primary objective of the study is to evaluate the efficacy of QA102 oral capsules on the development of soft drusen, visual acuity (VA), and geographic atrophy (GA) or choroidal neovascularization (CNV) or the progression of GA in subjects with intermediate to advanced dry AMD.
Conditions
- Dry Age-related Macular Degeneration
Interventions
QA102/PlaceboDrug
Capsules
QA102Drug
Capsules
PlaceboDrug
Capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Soft Drusen Volume (mm3)Time frame: Month 12
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Associated Retina Consultants
Phoenix, Arizona
Northern California Retina Vitreous Associates Medical Group
Mountain View, California
California Eye Specialists Medical Group
Pasadena, California
California Eye Specialists Medical Group
Redlands, California
Retina Consultants of Southern Colorado, P.C.
Colorado Springs, Colorado
Advanced Research
Deerfield Beach, Florida
National Ophthalmic Research Institute
Fort Myers, Florida
MedEye Associates
Miami, Florida
Retina Specialty Institute
Pensacola, Florida
Eye Associates of Pinellas
Pinellas Park, Florida
Sarasota Retina Institute
Sarasota, Florida
Vitreous and Retina Consultants
Winter Haven, Florida
Marietta Eye Clinic
Marietta, Georgia
University Retina and Macula Associates
Oak Forest, Illinois
Northeast Louisiana dba Haik Humble Eye Center
West Monroe, Louisiana
The Retina Care Center
Baltimore, Maryland
Cumberland Valley Retina Consultants
Hagerstown, Maryland
Mid Atlantic Retina Specialists
Hagerstown, Maryland
Vitreo-Retinal Associates, P.C.
Worcester, Massachusetts
Retina Research Institute
St Louis, Missouri
Velocity Clinical Research
Cincinnati, Ohio
Verum Research, LLC
Eugene, Oregon
Erie Retina Research
Erie, Pennsylvania
Retina Research Institute of Texas
Abilene, Texas
Austin Research Center for Retina
Austin, Texas
AXIS Clinicals LLC / Retina of North Texas
Dallas, Texas
Texas Retina Associates - Plano
Plano, Texas
San Antonio Eye Center
San Antonio, Texas
Rocky Mountain Retina Consultants
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.